AOD-9604 5MG

$49.99

SKU: NP-AOD96-5MG Category: Peptides

Description
Reviews (0)

Third-Party Lab Verified
HPLC + MS

Independently tested for identity and purity

Batch
NP-AOD9604-02

Tested
Aug 6, 2026

Purity
99.70%

AOD-9604

CAS# 221231-10-3

Also Known As hGH Fragment 176–191

Class Synthetic Peptide

Form Lyophilized Powder

β3-AR
Receptor Target

Lipolytic
Research Model

16 AA
Sequence Length

AOD-9604 (hGH Fragment 176–191, CAS# 221231-10-3) is a synthetic peptide corresponding to the C-terminal region of human growth hormone (hGH), spanning residues 176 to 191. The compound retains a disulfide bridge between its two cysteine residues, preserving a structural feature of the native hGH C-terminus. It is studied as a pharmacological tool for investigating lipolytic signalling, β3-adrenergic receptor interactions, and adipocyte biology in in vitro research models. Supplied by NexPept as a lyophilized powder for in vitro laboratory research use. This compound has not been authorized by Health Canada for any therapeutic, clinical, or human use.

Molecular Profile
CAS#, sequence, formula, molecular weight, analytical data

Property	Value
CAS Number	221231-10-3
Also Known As	hGH Fragment 176–191; Anti-Obesity Drug 9604
Parent Protein	Human Growth Hormone (hGH) — C-terminal fragment, residues 176–191
Sequence	Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe-NH₂
Molecular Formula	C₇₈H₁₂₃N₂₃O₂₃S₂
Molecular Weight	~1817 Da
Disulfide Bridge	Cys⁷–Cys¹⁴ intramolecular disulfide bond
Compound Class	Synthetic peptide — growth hormone-derived lipolytic fragment
Receptor Target	β3-Adrenergic receptor (β3-AR); lipolytic signalling pathway
Physical Form	Lyophilized powder
Analytical Method	High-Performance Liquid Chromatography (HPLC) + Mass Spectrometry (MS)
Appearance	White to off-white lyophilized solid

In Vitro Research Context
Receptor pharmacology — laboratory use only

β3-AR
Beta-3 adrenergic receptor — lipolytic cAMP signalling pathway research

Adipocyte Models
In vitro adipocyte differentiation and lipid accumulation research models

GH-Independent
Lipolytic activity independent of GH receptor and IGF-1 pathway studies

AOD-9604 is studied in preclinical in vitro settings as a pharmacological tool for investigating the lipolytic properties of the C-terminal region of human growth hormone, independently of GH receptor activation and IGF-1 axis signalling. Research applications include β3-adrenergic receptor binding assays, cAMP pathway activation studies, adipocyte lipolysis models, and transcriptomic analysis of lipid metabolism gene expression in adipose cell lines. The retention of the native Cys⁷–Cys¹⁴ disulfide bridge is studied for its role in maintaining the structural integrity of the lipolytic pharmacophore region.

Research context: AOD-9604 is an investigational compound studied in scientific research involving β3-adrenergic receptor pharmacology and lipolytic signalling pathways. Research into this compound remains ongoing. It has not been authorized by Health Canada for human or veterinary use.

Available Formats
5mg — lyophilized powder

Format	Net Quantity	Physical Form
AOD-9604 5mg	5 mg / vial	Lyophilized powder

Selection should be based on the quantity required for your specific in vitro research protocol as determined by qualified research personnel.

Laboratory Storage
Controlled storage conditions for lyophilized material

Store sealed lyophilized material under controlled laboratory conditions in accordance with validated institutional SOPs and applicable technical documentation. Protect from light and moisture. Handling conditions should be established by qualified research personnel in accordance with the specific experimental protocol.

Note: No preparation, reconstitution, or administration instructions are provided. This compound is supplied for in vitro laboratory research use only. All handling must be conducted by qualified personnel following institutional safety protocols.

Research Literature
Scientific references & related resources

PubMed — AOD-9604 / hGH Fragment 176–191 — peer-reviewed scientific literature on this compound

PubMed — GH Fragment Lipolytic Research — β3-AR and hGH C-terminal fragment pharmacology literature

Research Peptides in Canada — sourcing and research context for Canadian laboratories

What Are Research Peptides? — peptide classification and in vitro research context

⚠ Regulatory & Compliance Notice

This product is supplied exclusively for in vitro laboratory and non-clinical research use by qualified research personnel. It is not authorized by Health Canada for human or veterinary use. No therapeutic, clinical, or health claims are made.

This material must not be administered to humans or animals. No dosage, preparation, reconstitution, or administration instructions are provided or implied. All handling and use must be conducted by qualified personnel in accordance with applicable institutional policies and legal requirements.